Unlike regulators in the United States and Europe, the South African Health Products Regulatory Authority has not yet given the green light for any form of mix-and-match COVID-19 vaccine boosting. We take a look at the regulatory issues standing in the way of people in South Africa who received the Johnson & Johnson jab being offered Pfizer boosters.
It is estimated that around 45% of men and 48% of women older than 15 years have high blood pressure (hypertension) in South Africa and only about 19% of men and 29% of women who have this condition are aware that they have it. Elri Voigt unpacks the state of hypertension in the country and how it is diagnosed and treated.
Initially hamstrung by low and uncertain supplies of COVID-19 vaccines, government is arguably now in a better position to campaign actively to accelerate vaccine demand, albeit in the midst of an often-harmful viral “infodemic”. Chris Bateman asks what can be done to boost demand for the jab.
Just 54% of people in South Africa over the age of 50 have received at least one COVID-19 jab, with significant variation between provinces, as experts warn of the possibility of another wave of COVID-19 in future. Chris Bateman reports.
Government can avoid the overwhelming of health services and minimise death in an anticipated fourth COVID-19 wave in November/December by getting 90% of people in South Africa over 35 years old vaccinated before then. Life could then return to normal by Christmas, even with ongoing SARS-CoV-2 circulation, contends vaccinologist Professor Shabir Madhi.
New research published in the South African Medical Journal has found compelling evidence that a blanket ban on alcohol reduces the number of unnatural deaths related to trauma injuries while curfews have less of an impact. Adele Baleta spoke to lead author, Professor Tom Moultrie.
An experimental COVID-19 vaccine currently in Phase I trials being run by the University of Cape Town has a unique design that might allow it to offer better protection against current and future variants of the SARS-CoV-2 virus. Elri Voigt provides an update on the trial and unpacks the science behind this vaccine candidate.
Health Minister Dr Zweli Mkhize this week provided an update on investigations into a multimillion-rand NHI communications contract mired in controversy. That same morning, MPs in Parliament were again reminded of how critical an independent National Health Insurance Board will be. One organisation proposed an additional NHI corruption-fighting unit. Alicestine October has the latest from in and outside of Parliament.
When South Africa’s rollout of the AstraZeneca vaccine was put on hold in early February, a scramble ensued to ensure healthcare workers could be protected. Chris Bateman spoke to Professor Glenda Gray about the behind-the-scenes negotiations that helped secure 500 000 doses of the Johnson & Johnson vaccine – almost all of which have now been used in the Sisonke study.
COVID-19 numbers have in recent weeks been rising in the Free State, leading some to fear that the province might be at the beginning of a third wave of infections. Refilwe Mochoari asked the Department of Health, unions, and opposition political parties whether the province is ready for a third wave.
Wastewater surveillance has become an important part of South Africa’s COVID-19 monitoring systems and might even help to give early warning of a potential third wave of infections. Tiyese Jeranji looks at what is involved.
South Africa’s first National Tuberculosis Prevalence Survey found that many people without TB symptoms nevertheless have TB disease that can be detected using chest X-rays. Accordingly, new mobile X-ray screening programmes are being piloted in a number of provinces. Tiyese Jeranji reports.
